{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:24:09Z","timestamp":1774409049729,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K02 DA032322"],"award-info":[{"award-number":["K02 DA032322"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA043337"],"award-info":[{"award-number":["R01 DA043337"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K24 AG042489"],"award-info":[{"award-number":["K24 AG042489"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015270","name":"Ministry of Urban Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.conctc.2021.100704","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T08:15:45Z","timestamp":1610266545000},"page":"100704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Design and implementation of a prospective cohort study of persons living with and without HIV infection who are initiating medication treatment for opioid use disorder"],"prefix":"10.1016","volume":"21","author":[{"given":"Breanne E.","family":"Biondi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhasis","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent Vander","family":"Wyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth R.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert C.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra A.","family":"Springer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.conctc.2021.100704_bib1","series-title":"Provisional drug overdose death counts","author":"Ahmad","year":"2020"},{"issue":"50\u201351","key":"10.1016\/j.conctc.2021.100704_bib2","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths \u2014 United States, 2010\u20132015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"4","key":"10.1016\/j.conctc.2021.100704_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJMra1604339","article-title":"Treatment of opioid-use disorders","volume":"375","author":"Schuckit","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.conctc.2021.100704_bib5","series-title":"Taking Control: Pathways to Drug Policies That Work","year":"2014"},{"issue":"4","key":"10.1016\/j.conctc.2021.100704_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jsat.2005.02.007","article-title":"An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research","volume":"28","author":"Amato","year":"2005","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.conctc.2021.100704_bib7","series-title":"U.N.O.O.D.a. Crime, and UNAIDS, Substitution maintenance therapy in the management of opioid dependence and HIV\/AIDS prevention: Position Paper","year":"2004"},{"issue":"3","key":"10.1016\/j.conctc.2021.100704_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0740-5472(03)00029-1","article-title":"Adherence to methadone is associated with a lower level of HIV-related risk behaviors in drug users","volume":"24","author":"Wong","year":"2003","journal-title":"J. Subst. Abuse Treat."},{"issue":"1","key":"10.1016\/j.conctc.2021.100704_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1370\/afm.1735","article-title":"Geographic and specialty distribution of US physicians trained to treat opioid use disorder","volume":"13","author":"Rosenblatt","year":"2015","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.conctc.2021.100704_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2016.03.028","article-title":"Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City","volume":"164","author":"Hansen","year":"2016","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.conctc.2021.100704_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbi.2005.02.002","article-title":"Multiple opioid receptors on immune cells modulate intracellular signaling","volume":"20","author":"Sharp","year":"2006","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.conctc.2021.100704_bib12","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/infdis\/159.3.480","article-title":"Suppression of human peripheral blood mononuclear cell function by methadone and morphine","volume":"159","author":"Peterson","year":"1989","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.conctc.2021.100704_bib13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0022-3565(25)39466-8","article-title":"Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids","volume":"267","author":"Szabo","year":"1993","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1\u20132","key":"10.1016\/j.conctc.2021.100704_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-5728(02)00463-0","article-title":"Mu and delta receptors mediate morphine effects on phagocytosis by murine peritoneal macrophages","volume":"136","author":"Tomassini","year":"2003","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.conctc.2021.100704_bib15","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.4049\/jimmunol.180.5.3594","article-title":"Morphine induces defects in early response of alveolar macrophages to Streptococcus pneumoniae by modulating TLR9-NF-kappa B signaling","volume":"180","author":"Wang","year":"2008","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.conctc.2021.100704_bib16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/jim-50-06-03","article-title":"Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor","volume":"50","author":"Guo","year":"2002","journal-title":"J. Invest. Med."},{"issue":"1","key":"10.1016\/j.conctc.2021.100704_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0042-6822(03)00015-1","article-title":"Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication","volume":"309","author":"Steele","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.conctc.2021.100704_bib18","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3389\/fmicb.2015.01230","article-title":"Heroin inhibits HIV-restriction miRNAs and enhances HIV infection of macrophages","volume":"6","author":"Wang","year":"2015","journal-title":"Front. Microbiol."},{"issue":"10","key":"10.1016\/j.conctc.2021.100704_bib19","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1074\/jbc.M604367200","article-title":"Transcriptional and epigenetic regulation of interleukin-2 gene in activated T cells by morphine","volume":"282","author":"Wang","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.conctc.2021.100704_bib20","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1111\/j.1476-5381.2011.01513.x","article-title":"Opioids and the immune system: what is their mechanism of action?","volume":"164","author":"Eisenstein","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"37","key":"10.1016\/j.conctc.2021.100704_bib21","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.2174\/138161212803582496","article-title":"Non-analgesic effects of opioids: mechanisms and potential clinical relevance of opioid-induced immunodepression","volume":"18","author":"Sacerdote","year":"2012","journal-title":"Curr. Pharmaceut. Des."},{"issue":"7","key":"10.1016\/j.conctc.2021.100704_bib22","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/j.1476-5381.2011.01475.x","article-title":"Depletion and recovery of lymphoid subsets following morphine administration","volume":"164","author":"Zhang","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.conctc.2021.100704_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneuroim.2013.07.012","article-title":"Mu opioid receptor agonist-selective regulation of interleukin-4 in T lymphocytes","volume":"263","author":"Borner","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.conctc.2021.100704_bib24","article-title":"Methadone enhances human influenza A virus replication","author":"Chen","year":"2015","journal-title":"Addiction Biol."},{"issue":"7","key":"10.1016\/j.conctc.2021.100704_bib25","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.4049\/jimmunol.1302647","article-title":"Buprenorphine decreases the CCL2-mediated chemotactic response of monocytes","volume":"194","author":"Carvallo","year":"2015","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.conctc.2021.100704_bib26","doi-asserted-by":"crossref","first-page":"s9","DOI":"10.1191\/0269216306pm1124oa","article-title":"Opioids and the immune system","volume":"20","author":"Sacerdote","year":"2006","journal-title":"Palliat. Med."},{"issue":"2","key":"10.1016\/j.conctc.2021.100704_bib27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inf."},{"issue":"RR-14","key":"10.1016\/j.conctc.2021.100704_bib29","first-page":"1","article-title":"Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings","volume":"55","author":"Branson","year":"2006","journal-title":"MMWR Recomm. Rep. (Morb. Mortal. Wkly. Rep.)"},{"issue":"6","key":"10.1016\/j.conctc.2021.100704_bib30","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.conctc.2021.100704_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the addiction severity Index","volume":"9","author":"McLellan","year":"1992","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.conctc.2021.100704_bib32","series-title":"The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Manual for Use in Primary Care","year":"2010"},{"key":"10.1016\/j.conctc.2021.100704_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.drugalcdep.2014.10.002","article-title":"Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients","volume":"145","author":"McHugh","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"10.1016\/j.conctc.2021.100704_bib34","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.conctc.2021.100704_bib35","first-page":"351","article-title":"Development of the world health organization WHOQOL-BREF quality of life assessment","volume":"28","year":"1998","journal-title":"Psychol. Med."},{"issue":"20","key":"10.1016\/j.conctc.2021.100704_bib36","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatr."},{"issue":"6","key":"10.1016\/j.conctc.2021.100704_bib37","doi-asserted-by":"crossref","first-page":"681","DOI":"10.15288\/jsa.1998.59.681","article-title":"Self-reports of alcohol use, drug use and sexual behavior: expanding the Timeline Follow-back technique","volume":"59","author":"Midanik","year":"1998","journal-title":"J. Stud. Alcohol"},{"key":"10.1016\/j.conctc.2021.100704_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2014.10.010","article-title":"CyTOF supports efficient detection of immune cell subsets from small samples","volume":"415","author":"Yao","year":"2014","journal-title":"J. Immunol. Methods"},{"issue":"3","key":"10.1016\/j.conctc.2021.100704_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008112","article-title":"Single cell immune profiling of dengue virus patients reveals intact immune responses to Zika virus with enrichment of innate immune signatures","volume":"14","author":"Zhao","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"7","key":"10.1016\/j.conctc.2021.100704_bib40","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/infdis\/jiu573","article-title":"Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adults","volume":"211","author":"Mohanty","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.conctc.2021.100704_bib41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.18632\/aging.100720","article-title":"Aging-dependent alterations in gene expression and a mitochondrial signature of responsiveness to human influenza vaccination","volume":"7","author":"Thakar","year":"2015","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.conctc.2021.100704_bib42","series-title":"CBMS-NSF Regional Conference Series in Applied Mathematics","article-title":"Spline models for observational data","author":"Wahba","year":"1990"},{"issue":"15","key":"10.1016\/j.conctc.2021.100704_bib43","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/jnci\/80.15.1198","article-title":"Regression models in clinical studies: determining relationships between predictors and response","volume":"80","author":"Harrell","year":"1988","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.conctc.2021.100704_bib44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.conctc.2021.100704_bib45","series-title":"A Method\/macro Based on Propensity Score and Mahalanobis Distance to Reduce Bias in Treatment Comparison in Observational Study","author":"Feng","year":"2005"},{"issue":"8 Pt 2","key":"10.1016\/j.conctc.2021.100704_bib46","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7326\/0003-4819-127-8_Part_2-199710151-00064","article-title":"Estimating causal effects from large data sets using propensity scores","volume":"127","author":"Rubin","year":"1997","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.conctc.2021.100704_bib47","series-title":"Analysis of Longitudinal Data","author":"Diggle","year":"1994"},{"key":"10.1016\/j.conctc.2021.100704_bib48","series-title":"Generalized, Linear and Mixed Models","author":"McCulloch","year":"2001"},{"key":"10.1016\/j.conctc.2021.100704_bib49","series-title":"Statistical Analysis with Missing Data","author":"Little","year":"2002"},{"key":"10.1016\/j.conctc.2021.100704_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1214\/aos\/1176344552","article-title":"Bootstrap methods: another look at the jackknife","volume":"7","author":"Efron","year":"1979","journal-title":"Ann. Stat."},{"key":"10.1016\/j.conctc.2021.100704_bib51","series-title":"Multiple Comparisons and Multiple Tests Using SAS","author":"Westfall","year":"2011"},{"key":"10.1016\/j.conctc.2021.100704_bib52","series-title":"L.M., HIV in Prisons, 2015-Statistical Tables","author":"Bronson","year":"2017"},{"key":"10.1016\/j.conctc.2021.100704_bib53","series-title":"Drug Use, Dependence, and Abuse Among State Prisoners and Jail Inmates, 2007-2009","author":"Bronson","year":"2017"},{"issue":"1","key":"10.1016\/j.conctc.2021.100704_bib54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jsat.2007.08.004","article-title":"Buprenorphine\/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors","volume":"35","author":"Sullivan","year":"2008","journal-title":"J. Subst. Abuse Treat."},{"issue":"4","key":"10.1016\/j.conctc.2021.100704_bib55","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jsat.2010.07.009","article-title":"The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment","volume":"39","author":"Pinto","year":"2010","journal-title":"J. Subst. Abuse Treat."},{"issue":"4","key":"10.1016\/j.conctc.2021.100704_bib56","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1360-0443.1998.9344753.x","article-title":"Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial","volume":"93","author":"Ling","year":"1998","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.conctc.2021.100704_bib57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.conctc.2021.100704_bib58","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S146114570700836X","article-title":"Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study","volume":"11","author":"Soyka","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.conctc.2021.100704_bib59","doi-asserted-by":"crossref","first-page":"e38335","DOI":"10.1371\/journal.pone.0038335","article-title":"Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners","volume":"7","author":"Springer","year":"2012","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.conctc.2021.100704_bib60","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","article-title":"Retention in medication-assisted treatment for opiate dependence: a systematic review","volume":"35","author":"Timko","year":"2016","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.conctc.2021.100704_bib61","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X: BOT): a multicentre, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.conctc.2021.100704_bib62","series-title":"Centers for Disease Control and Prevention, HIV Surveillance Report, 2018 (Updated)","year":"2020"},{"key":"10.1016\/j.conctc.2021.100704_bib63","series-title":"UNODC, UNAIDS Technical Guide for Countries to Set Targets for Universal Access to HIV Prevention, Treatment and Care for Injecting Drug Users\u20132012 Revision","year":"2012"}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865421000077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865421000077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:03:14Z","timestamp":1762520594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865421000077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":61,"alternative-id":["S2451865421000077"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2021.100704","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and implementation of a prospective cohort study of persons living with and without HIV infection who are initiating medication treatment for opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2021.100704","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100704"}}